The role of protein kinase C- II (PKC- II ) in etoposide (VP-16)-induced apoptosis was studied using polyomavirus-transformed pyF111 rat fibroblasts in which PKC- II specific activity in the nuclear membrane (NM) doubled and the enzyme was cleaved into catalytic fragments. No PKC- II complexes with lamin B1 and/or active caspases were immunoprecipitable from the NM of proliferating untreated cells, but large complexes of PKC- II holoprotein and its catalytic fragments with lamin B1, active caspase-3 and -6, and inactive phospho-CDK-1, but not PKC- I or PKC-␦, could be immunoprecipitated from the NM of VP-16-treated cells, suggesting that PKC- II is an apoptotic lamin kinase. By 30 min after normal nuclei were mixed with cytoplasms from VP-16-treated, but not untreated, cells, PKC- II holoprotein had moved from the apoptotic cytoplasm to the normal NM, and lamin B1 was phosphorylated before cleavage by caspase-6. Lamin B1 phosphorylation was partly reduced, but its cleavage was completely prevented, despite the presence of active caspase-6, by adding a selective PKC-s inhibitor, hispidin, to the apoptotic cytoplasms. Thus, a PKC- II response to VP-16 seems necessary for lamin B1 cleavage by caspase-6 and nuclear lamina dissolution in apoptosing pyF111 fibroblasts. The possibility of PKC- II being an apoptotic lamin kinase in these cells was further suggested by lamin B1-bound PKC-␦ being inactive or only slightly active and by PKC-␣ not combining with the lamin.A growing body of evidence suggests that the commitment to and execution of apoptosis are mediated through the phosphorylation of specific proteins by several protein kinases (1). A number of PKC 1 isoforms appear to be among these protein kinases (2, 3). Apoptogens may activate or inactivate and cause the translocation of various PKC isoforms from the cytosol onto cytoskeletal components, cytoplasmic membranes, mitochondria, and/or the nuclear envelope (4 -11); induce their migration from such subcellular structures to nucleoplasmic and/or cytosolic fractions (8, 12); or cause the PKC holoenzymes to be cleaved into N-terminal regulatory and C-terminal catalytic fragments (CFs) by several proteases, including caspases (11,(13)(14)(15). Despite suggestions that a particular PKC isoform (e.g. the novel PKC-␦ and/or its CFs) might play a pivotal role in apoptosis (13,14), the available evidence indicates the involvement and cleavage of novel PKCs (e.g. PKC-⑀ and PKC-), the classical Ca 2ϩ -stimulable PKCs (e.g. PKC-), atypical PKCs (e.g. PKC-), and PKC-related (e.g. PRK) kinases in apoptosis (2,3,15). This is the third report from a continuing study of the roles of protein kinase C isozymes in drug-induced apoptosis using a polyomavirus-transformed embryo rat fibroblast, the pyF111 cell, as a model (10, 11). We chose this fibroblast, since it is prone to apoptosis because it cannot make the antiapoptotic Bcl-2 and Bcl-X L proteins but can make the proapoptotic Bax protein (10, 11). We have shown that whereas a surge of the activity of PKC-␦ holopr...